Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SNDX - Syndax Pharmaceuticals Inc. (SNDX) CEO Michael Metzger on Q1 2022 Results - Earnings Call Transcript

SNDX - Syndax Pharmaceuticals Inc. (SNDX) CEO Michael Metzger on Q1 2022 Results - Earnings Call Transcript

Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals, Inc. (SNDX) Q1 2022 Earnings Conference Call May 09, 2022 04:30 PM ET Company Participants Maghan Meyers - Vice President, Argot Partners Michael Metzger - Chief Executive Officer Briggs Morrison - President & Head, R&D Alex Nolte - Chief Accounting Officer Peter Ordentlich - Chief Scientific Officer Conference Call Participants Madhu Kumar - Goldman Sachs Phil Nadeau - Cowen & Company Bert Hazlett - BTIG Ashiq Mubarack - Citigroup Joel Beaty - Baird Peter Lawson - Barclays Presentation Operator Good day and welcome to the Syndax First Quarter 2022 Earnings Conference Call. Today's call is being recorded. At this time I would like to turn the call over to Maghan Meyers of Argot Partners. Please begin. Maghan Meyers Thank you, Operator. Welcome and thank you to those of you joining us on the line and the webcast this afternoon for a review of Syndax's first quarter 2022 financial

For further details see:

Syndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Syndax Pharmaceuticals Inc.
Stock Symbol: SNDX
Market: NASDAQ
Website: syndax.com
Menu
SNDX SNDX Quote SNDX Short SNDX News SNDX Articles SNDX Message Board
Get SNDX Alerts

News, Short Squeeze, Breakout and More Instantly...